Preiss Joshua E, Arya Shipra, Duwayri Yazan, Shafii Susan M, Veeraswamy Ravi K, Rajani Ravi R, Dodson Thomas F, Brewster Luke P
Department of Surgery, Emory University, Atlanta, GA.
Department of Surgery, Emory University, Atlanta, GA; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA; Surgical and Research Services, Atlanta VA Medical Center, Atlanta, GA.
J Surg Res. 2015 Oct;198(2):508-14. doi: 10.1016/j.jss.2015.04.003. Epub 2015 Apr 4.
Abdominal aortic aneurysm (AAA) rupture is an adverse arterial remodeling event with high mortality risk. Because females have increased rupture risk with smaller AAAs (<5.5 cm), many recommend elective repair before the AAA reaches 5.5 cm. Elective repair improves survival for large AAAs, but long-term benefits of endovascular aneurysm repair (EVAR) for small AAAs in females remain less understood. The objective of this study was to identify if differences in late mortality exist between females undergoing elective EVAR at our institution for small and/or slow-growing AAAs compared with those who meet standard criteria.
We retrospectively analyzed all patients that underwent EVAR for infrarenal AAA from June, 2009-June, 2013. We excluded patients that were male, treated emergently or for iliac artery aneurysm, and that received renal and/or mesenteric artery stenting. Patients did not meet anatomic criteria if preoperative AAA diameter was <5.5 cm or enlarged <0.5 cm over 6 mo. Late mortality was assessed from the social security death index.
Thirty-six of 162 elective EVAR patients (22.2%) were female (mean follow-up, 37.2 mo). Twenty patients (55.6%) met AAA size and/or growth criteria, whereas 16 (44.4%) did not meet criteria. Despite comparable demographics, comorbidities, and complications, patients that did not meet criteria had higher late mortality (37.5% versus 5%; P = 0.03) with a trend toward increased reoperation rate (25% versus. 5%; P = 0.48). Meeting size and/or growth criteria decreased odds of late death (odds ratio, 0.09; 95% confidence intervals, 0.01-0.83).
There is increased late mortality in females receiving elective EVAR at our institution for small and/or slow-growing AAAs. This late mortality may limit the benefits of EVAR for this population.
腹主动脉瘤(AAA)破裂是一种不良的动脉重塑事件,具有较高的死亡风险。由于女性AAA直径较小时(<5.5厘米)破裂风险增加,许多人建议在AAA达到5.5厘米之前进行择期修复。择期修复可提高大型AAA患者的生存率,但对于女性小型AAA的血管内动脉瘤修复(EVAR)的长期益处仍了解较少。本研究的目的是确定在我们机构接受择期EVAR治疗的小型和/或生长缓慢的AAA女性患者与符合标准标准的女性患者相比,晚期死亡率是否存在差异。
我们回顾性分析了2009年6月至2013年6月期间接受肾下腹主动脉瘤EVAR治疗的所有患者。我们排除了男性患者、急诊治疗或髂动脉瘤患者,以及接受肾和/或肠系膜动脉支架置入的患者。如果术前AAA直径<5.5厘米或在6个月内增大<0.5厘米,则患者不符合解剖学标准。通过社会保障死亡指数评估晚期死亡率。
162例择期EVAR患者中有36例(22.2%)为女性(平均随访37.2个月)。20例(55.6%)符合AAA大小和/或生长标准,而16例(44.4%)不符合标准。尽管人口统计学、合并症和并发症相似,但不符合标准的患者晚期死亡率更高(37.5%对5%;P=0.03),再次手术率有增加趋势(25%对5%;P=0.48)。符合大小和/或生长标准可降低晚期死亡几率(优势比,0.09;95%置信区间,0.01-0.83)。
在我们机构接受择期EVAR治疗的小型和/或生长缓慢的AAA女性患者中,晚期死亡率增加。这种晚期死亡率可能会限制EVAR对该人群的益处。